Vers la page d'accueil
820К+ patients ont reçu de l'aide depuis 2014
50 pays
1,500 cliniques
6K+ avis
3K+ médecins qualifiés

Quel est le Coût du Diagnostic et du Traitement de lymphome en République de Corée ?

Le prix moyen du diagnostic et du traitement de lymphome en République de Corée est $88,758, le plus bas étant $1,060 et le plus haut $275,000.
République de CoréeTurquieEspagne
Une greffe de moelle osseusede $55,000de $36,000de $71,782
Transplantation allogénique de moelle osseuse provenant d'un donneur non apparentéde $145,000de $80,000de $150,000
Transplantation allogénique de moelle osseuse d'un donneur apparentéde $75,000de $65,000de $13,670
Thérapie CAR Tde $385,000de $150,000de $330,000
Greffe de moelle osseuse autologuede $42,000de $31,500de $40,000
Données vérifiées par Bookimed en July 2026, sur la base des demandes des patients et des devis officiels de 116 cliniques dans le monde. Les coûts médians sont calculés à partir de factures réelles (2025–2026) et mis à jour chaque mois. Les prix réels peuvent varier.

Vos avantages et garanties avec Bookimed

Prix directs

Bookimed ne rajoute pas de frais pour les traitements de Lymphome. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.

Cliniques et médecins vérifiés uniquement

Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Lymphome et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.

Assistance gratuite 24/7

Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Lymphome.

Pourquoi nous ?

Votre coordinateur médical personnel

  • Vous soutient à chaque étape
  • Aide à choisir la bonne clinique et le bon médecin
  • Assure un accès rapide et pratique à l'information

Découvrez les Meilleures Cliniques pour le Traitement de lymphome en République de Corée : 9 Options Vérifiées et Prix

Le classement des cliniques Bookimed est basé sur des algorithmes de science des données, offrant une comparaison fiable, transparente et objective. Il prend en compte la demande des patients, les notes d'évaluation (positives et négatives), la fréquence des mises à jour des options de traitement et des prix, la vitesse de réponse et les certifications des cliniques.
Samsung Medical Center
Ewha Womans University Medical Center
Seoul National University Bundang Hospital (SNUBH)
Asan Medical Center
Gachon University Gil Medical Center

Partager ce contenu

Histoires vidéo des patients de Bookimed

Dayana
J'ai combiné mes vacances à Antalya avec un bilan de santé.
Procédure: Bilan féminin
Igor
C'était génial ! Transferts, hébergement, traitement – tout était inclus.
Procédure: Implant dentaire
Clinique: WestDent Clinic
Marina
Bookimed s’est occupé de tout. Je n’avais aucun souci à me faire.
Procédure: Bilan féminin
Mis à jour: 05/27/2022
Rédigé par
Anna Leonova
Anna Leonova
Responsable de l'équipe marketing de contenu
Auteur médical certifié avec 10+ ans d'expérience, créateur des contenus fiables de Bookimed, soutenus par un Master en philologie et des interviews avec des experts médicaux internationaux.
Fahad Mawlood
Éditeur Médical et Scientifique des Données
Praticien généraliste. Lauréat de 4 prix scientifiques. Diplômé en Asie occidentale. Ancien Chef d'une équipe médicale aidant les patients arabes. Aujourd'hui responsable du traitement des données et de l'exactitude du contenu médical.
Fahad Mawlood Linkedin
Cette page peut contenir des informations relatives à diverses conditions médicales, traitements et services de santé disponibles dans différents pays. Veuillez noter que le contenu est fourni à des raisons d'information seulement et ne devrait pas être interprété comme conseil médical. Veuillez consulter votre médecin ou un professionnel de la santé qualifié avant d'entreprendre ou de changer de traitement médical.

FAQ sur le Traitement de lymphome en République de Corée

Ces FAQ sont basées sur les questions de patients réels cherchant des soins médicaux avec Bookimed. Les réponses sont fournies par des experts médicaux et des représentants de cliniques réputées.

What are the reported remission success rates for lymphoma chemotherapy in Korea?

Lymphoma chemotherapy in Korea achieves remission rates between 85% and 90% for early-stage patients. Specialized clinical studies report an 87.6% complete remission rate for Hodgkin’s lymphoma. Aggressive B-cell subtypes like DLBCL reach approximately 84% remission. Major Seoul centers use advanced protocols for these results.

  • Hodgkin’s lymphoma: Remission rates reach 93% for early-stage cases using combined modality therapy.
  • DLBCL outcomes: Standard R-CHOP therapy achieves a 84.2% complete remission rate for patients.
  • T-cell lymphoma: NK/T-cell lymphoma protocols show remission success in 71% to 78% of cases.
  • Burkitt lymphoma: Specific R-hyper-CVAD regimens report a 75% complete remission rate in Korea.

Bookimed Expert Insight: Data shows a high concentration of expertise in Seoul. Facilities like Samsung Medical Center and Severance Hospital manage over 2 million patients annually. These high-volume centers report remission rates comparable to Western benchmarks. This is due to their rapid adoption of digital systems. Seoul National University Hospital has been fully digitalized since 2004. This digital accuracy helps specialists refine chemotherapy dosing for complex lymphoma subtypes.

Patient Consensus: Patients note that Korean protocols are intensive. They emphasize the importance of reaching clear PET scans early in the treatment process.

Is CAR T-cell therapy available for lymphoma patients in South Korea?

CAR T-cell therapy is available for lymphoma patients at several licensed medical centers in South Korea. Major institutions provide approved therapies like Kymriah and Yescarta for relapsed or refractory diffuse large B-cell lymphoma. Local centers often collaborate on domestic clinical trials to expand treatment accessibility.

  • Available therapies: Kymriah and Yescarta are approved for adult relapsed DLBCL cases.
  • Domestic options: South Korea approved Limcato in 2026 as its first homegrown therapy.
  • Licensed institutions: Approximately 14 hospitals like Samsung Medical Center are authorized for administration.
  • Diagnostic precision: Facilities use advanced PET/CT and cytogenetic bone marrow analysis for staging.
  • Treatment volume: Asan Medical Center treats over 180,000 patients annually with multidisciplinary oncology teams.

Bookimed Expert Insight: While South Korea ranks eighth globally in medical requests, its oncology infrastructure is exceptionally concentrated. Samsung Medical Center and Severance Hospital manage over 6,000,000 patients combined each year. This massive volume allows these centers to maintain dedicated CAR T-cell units. Such specialization often leads to smoother logistics for complex cellular processing than smaller regional hubs.

Patient Consensus: Patients note it is important to confirm eligibility through telemedicine before traveling for aggressive B-cell lymphoma treatments. Many highlight that coordinating professional translation and post-treatment monitoring is essential for a smooth experience at Seoul hospitals.

Which hospitals are considered leading centers for lymphoma treatment in Korea?

Leading centers for lymphoma treatment in South Korea include Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital. These Seoul-based institutions provide advanced therapies like CAR-T cell therapy and hematopoietic stem cell transplants. Most facilities hold JCI or KOIHA accreditations for oncology excellence.

  • Asan Medical Center: Performs 65,000+ yearly operations with a high-volume bone marrow transplantation program.
  • Samsung Medical Center: Offers CAR-T cell therapy for refractory B-cell lymphoma with presidential-standard facilities.
  • Seoul National University Hospital: Performed 3,500+ hematopoietic stem cell transplants using advanced precision medicine protocols.
  • Severance Hospital: Features the country's first carbon-ion therapy facility for treating aggressive lymphoma cases.
  • SNU Bundang Hospital: Utilizes the BESTcare digital system to enhance diagnostic accuracy for refractory cancers.

Bookimed Expert Insight: Patient volume often indicates specialized expertise in Korea. Severance Hospital and Samsung Medical Center handle high annual patient counts, exceeding 2,000,000 people each. Our data shows these large academic centers often centralize clinical trials for immunotherapy. Choosing a high-volume center in Seoul typically ensures access to newer drug-based protocols not available regionally.

Patient Consensus: Patients emphasize seeking second opinions at multiple Seoul-based clinics to confirm aggressive lymphoma diagnoses. Many note that major teaching hospitals provide better English-speaking support for international oncology coordination.

Can Western lymphoma therapies be combined with Korean Traditional Medicine?

Integrating Western lymphoma therapies with Korean Traditional Medicine (KTM) is a standard practice in Seoul medical centers. Specialized hospitals combine chemotherapy or immunotherapy with acupuncture and herbal medicine. These protocols manage side effects like neuropathy and fatigue while supporting immune function during rigorous treatment cycles.

  • Symptom management: Acupuncture and moxibustion alleviate chemotherapy-induced nausea and peripheral neuropathy.
  • Immune support: Herbal formulas like Bojungikki-tang potentially enhance modern PD-1 blockade immunotherapy effects.
  • Integrated facilities: Specialized centers like Kyung Hee University Hospital offer supervised Western-KTM collaboration.
  • Safety monitoring: Medical teams track liver enzymes to prevent herb-drug interactions during chemotherapy.

Bookimed Expert Insight: Samsung Medical Center and Severance Hospital use digital systems like BESTcare to coordinate complex treatments for millions of patients. Our data shows that top-tier Seoul facilities often have KTM-integrated oncology referrals nearby. Patients should choose JCI-accredited hospitals that offer multidisciplinary tumor boards. These boards ensure traditional herbs do not interfere with advanced treatments like CAR T-cell therapy.

Patient Consensus: Patients note that getting oncologist approval for mild herbal teas often helps with post-chemo recovery and nausea. Many advise sticking strictly to hospital-approved herbs rather than over-the-counter options to avoid dangerous drug interactions.

What clinical documents should international patients bring for a lymphoma treatment plan?

Patients must bring complete medical records, including pathology slides, digital imaging, and detailed treatment logs. These documents ensure accurate diagnostic review and prevent treatment delays. South Korean cancer centers require recent scans and certified translations to confirm lymphoma staging and previous chemotherapy cycles.

  • Pathology materials: Bring physical glass slides and paraffin blocks for review.
  • Digital imaging: Provide original PET-CT and MRI scans in DICOM format.
  • Treatment records: Include specific chemotherapy drug names, dosages, and total cycles.
  • Blood results: Present recent panels including CBC, LDH, and beta-2 microglobulin.
  • Genetic data: Share molecular testing results like MYC or BCL2 markers.

Bookimed Expert Insight: Advanced centers like Samsung Medical Center and Asan Medical Center handle massive patient volumes, often exceeding 180,000 annually. This high traffic means diagnostic departments prioritize digital records over paper files for faster processing. Patients should bring three physical copies of all records, but keeping everything on a USB drive is the most efficient way to ensure Korean oncologists can integrate your history into their digital BESTcare systems immediately.

Patient Consensus: Patients emphasize that bringing physical pathology slides is essential to avoid repetitive biopsies that can cost $2,000. It is also important to have all files translated into Korean or English at least four weeks before traveling.

Where are Korea’s main medical hubs for lymphoma care located?

Seoul and Incheon serve as the primary hubs for lymphoma care in South Korea. These cities host Joint Commission International-accredited centers. They specialize in CAR T-cell therapy and bone marrow transplants. Patients access advanced diagnostics like PET-CT and cytogenetic analysis at these facilities.

  • Seoul oncology district: Houses Samsung Medical Center with dedicated CAR T-cell programs.
  • National Cancer Center: Located in Gyeonggi-do, this government facility leads in proton therapy.
  • Incheon medical hub: Gachon University Gil Medical Center provides multidisciplinary care near the airport.
  • Bone marrow focus: Seoul National University Hospital has performed over 3,500 bone marrow transplants.

Bookimed Expert Insight: Seoul centers demonstrate high-volume expertise rarely seen elsewhere. Asan Medical Center serves over 11,000 outpatients daily. This massive scale allows clinics like Seoul National University Bundang Hospital to implement digital systems that reduce medical errors. If seeking complex transplants, focusing on these high-capacity Seoul institutions ensures access to larger hematology teams.

Patient Consensus: Patients note that Seoul centers often provide faster treatment starts for aggressive lymphomas compared to US facilities. They frequently mention the benefit of having English-speaking coordinators at Samsung Medical Center to help navigate complex therapy schedules.

Does the Republic of Korea offer advanced CAR-T cell therapy for lymphoma treatment?

The Republic of Korea offers specialised CAR-T cell therapy for lymphoma. Major Seoul-based centres provide Kymriah and Yescarta for relapsed cases. Facilities like Samsung Medical Center and Seoul National University Hospital administer these engineered immune cell treatments. They focus on diffuse large B-cell lymphoma.

  • Authorised centres: Samsung Medical Center and Seoul National University Hospital are key providers.
  • Clinical trials: Next-generation CAR-T trials by domestic firms like Curocell target refractory cases.
  • Accredited facilities: Leading centres hold JCI and KOIHA certifications for safety.
  • Innovation: Domestic CAR-T therapy development aims to improve local treatment accessibility.

Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually. It also holds Newsweek Best Hospital rankings. This high volume across multidisciplinary units supports managed care for complex CAR-T side effects. Smaller centres may not match this specific intensive care infrastructure.

Patient Consensus: Patients note it is important to confirm clinical trial availability for specific lymphoma subtypes. It is also helpful to arrange telehealth follow-up with Korean specialists before returning home to Australia.

What are the leading hospitals in the Republic of Korea for lymphoma treatment?

Leading South Korean hospitals for lymphoma treatment include Samsung Medical Center, Asan Medical Center, and Severance Hospital. These Seoul-based institutions provide CAR T-cell therapy and bone marrow transplants. Most major centres hold JCI accreditation. They manage over 1,000,000 patients annually with integrated oncology teams.

  • Samsung Medical Center: Provides CAR T-cell units and IGRT within its Comprehensive Cancer Centre.
  • Asan Medical Center: Operates the largest multidisciplinary facility in Korea with specialised bone marrow transplantation programs.
  • Severance Hospital: Holds JCI accreditation and manages over 1.6 million outpatients annually with interdisciplinary care.
  • SNUBH: Uses the BESTcare digital system to enhance safety and reduce errors during treatment.

Bookimed Expert Insight: Samsung Medical Center and Severance Hospital offer a distinct advantage for Australian patients. Their JCI accreditation and massive surgical volumes provide high levels of clinical expertise. Severance Hospital alone performs approximately 45,800 operations yearly. This high frequency often leads to more refined clinical pathways for complex lymphoma cases.

Patient Consensus: Patients value Seoul tertiary hospitals for managing the entire pathway on-site. This includes everything from pathology and PET-CT scans to chemotherapy. They recommend confirming English-language support for medical reports to help with follow-up care in Australia.

Are there English-speaking specialists available for lymphoma treatment in the Republic of Korea?

Dozens of English-speaking lymphoma specialists practise at JCI-accredited tertiary centres in Seoul. These experts treat approximately 1,200 international patients annually. Most leading oncologists hold Western fellowships. Clinics like Samsung Medical Center and Severance Hospital provide dedicated coordinators for clear communication during chemotherapy or transplant cycles.

  • Accredited facilities: Six major Seoul hospitals hold JCI or GHA international quality certifications.
  • Specialised procedures: Specialists perform CAR T-cell therapy and allogenic bone marrow transplants regularly.
  • Digital systems: Seoul National University Hospital uses fully digital records to avoid medical errors.
  • Patient support: International centres provide interpreters for consent discussions and pathology report explanations.

Bookimed Expert Insight: Many doctors understand clinical English. However, patients should select centres like Samsung Medical Center with 2,000,000+ annual patients. These high-volume hubs have the most refined international departments. Our data shows that top-tier facilities often employ coordinators who stay throughout chemo sessions. This is vital for managing immediate side effects or questions.

Patient Consensus: Patients note that many specialists speak basic English. Having a dedicated interpreter in the Republic of Korea helps patients fully understand complex diagnosis details and follow-up plans.

What technologies are used in the Republic of Korea for the staging and treatment of lymphoma?

The Republic of Korea uses high-precision imaging and cellular therapies for lymphoma staging and treatment. Major Seoul centres employ PET-CT scans, cytogenetic bone marrow analysis, and CAR T-cell therapy. Licensed facilities like Samsung Medical Center and Asan Medical Center provide these technologies within JCI-accredited infrastructures.

  • Diagnostic imaging: PET-CT scans precisely map lymphoma spread for accurate clinical staging.
  • Genomic staging: Bone marrow puncture with cytogenetic analysis identifies specific mutations for targeted therapy.
  • Cellular therapy: CAR T-cell therapies like Limcato treat relapsed or refractory diffuse large B-cell lymphoma.
  • Precision radiation: Samsung Medical Center uses Novalis radiosurgery and image-guided radiation therapy (IGRT).
  • Supportive transplants: Major facilities offer various bone marrow transplant types, including allogenic and autologous.

Bookimed Expert Insight: Many countries offer CAR T-cell therapy. South Korea has moved toward self-sufficiency with its homegrown therapy, Limcato. Samsung Medical Center and Asan Medical Center handle vast patient volumes. These often exceed 180,000 cases annually. This volume helps clinical teams build deep expertise in managing complex immunotherapy reactions and post-transplant recovery.

Patient Consensus: Patients in South Korea highlight that centres use PET-CT based staging for specific lymphoma subtypes. They note that hospital teams effectively coordinate bone marrow biopsies and pathology reviews for international visitors.

How are international patients supported during lymphoma treatment at hospitals in the Republic of Korea?

International patients in South Korea receive support through dedicated healthcare centres. These hubs provide multilingual coordination and streamlined medical paths. Facilities like Severance Hospital and Samsung Medical Center offer JCI-accredited care. These centres fast-track biopsies and PET-CT scans so lymphoma treatment starts within days of arrival.

  • Expert coordination: Dedicated staff manage pathology reports, schedule appointments, and assist with visa extensions.
  • Language support: In-house interpreters assist with consultations and chemotherapy sessions at major Seoul hospitals.
  • Digital records: Centres like SNUH provide digitalised English medical reports for easy discharge follow-up.
  • Quality standards: Many hospitals hold Newsweek rankings and JCI accreditation for international safety outcomes.

Bookimed Expert Insight: High-volume centres like Samsung Medical Center serve over 2,000,000 patients annually. For lymphoma, this volume allows doctors to handle highly specific subtypes. Hospitals like SNUBH use the BESTcare digital system. This reduces medical errors by instantly sharing precise diagnostic data across multidisciplinary teams.

Patient Consensus: Patients note that larger tertiary hospitals provide the best practical help with paperwork and transport. To help with follow-up care in Australia, patients recommend requesting all pathology reports in English before leaving Korea.

Obtenez une consultation gratuite

Sélectionnez la meilleure façon de vous contacter